Megan Jajou, PA
Payments from drug & device makers
Across 133 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$483
- AbbVie$395
- Regeneron Healthcare Solutions, Inc.$287
- Amgen$193
- Incyte Corporation$153
- Sanofi$130
- plus $969 from 20 others
What the payments were for
- Food & beverage$2,51096%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 27 | $483 |
| AbbVie | 20 | $395 |
| Regeneron Healthcare Solutions, Inc. | 13 | $287 |
| Amgen | 11 | $193 |
| Incyte Corporation | 7 | $153 |
| Sanofi | 7 | $130 |
| Dermavant Sciences, Inc. | 5 | $103 |
| Sun Pharmaceutical Industries Inc. | 5 | $99 |
| UCB, Inc. | 3 | $93 |
| Lilly USA, LLC | 4 | $78 |
| Organon | 3 | $61 |
| Pfizer | 3 | $59 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Novartis | 2 | $50 |
| VYNE Pharmaceuticals Inc. | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $39 |
| LEO Pharma Inc. | 2 | $37 |
| Galderma Laboratories, L.p. | 2 | $35 |
| Biofrontera Inc. | 3 | $34 |
| Boehringer Ingelheim | 1 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| AstraZeneca | 1 | $21 |
| Krystal Biotech Inc | 1 | $20 |
| Almirall LLC | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $14 |
How this compares
$2,610 in reported general payments places this provider in the 75th percentile of 755 medical providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 33 | $817 |
| Clobetasol Propionate | 24 | $700 |
| Fluticasone Propionate | 40 | $649 |
| Triamcinolone Acetonide | 59 | $619 |
| Ketoconazole | 27 | $387 |
| Metronidazole | 11 | $367 |
| CiclopiroxCiclopirox Olamine | 23 | $346 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 15 | $314 |
| Mupirocin | 28 | $265 |
| Hydrocortisone | 27 | $148 |
| Minoxidil | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other medical in Troy
- Kathleen AllorTroy$15K
- Beth BeleskyTroy$8K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.